REVANCE THERAPEUTICS INC shareholders Q4 2022

REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 195 filers reported holding REVANCE THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.35 and the average weighting 0.2%.

REVANCE THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Caption Management, LLC 845,800$15,613,4680.24%
Granahan Investment Management 348,064$6,425,2610.20%
ESSEX INVESTMENT MANAGEMENT CO LLC 67,933$1,2540.20%
Walleye Capital LLC 508,695$9,390,5100.17%
Holocene Advisors, LP 1,306,660$24,120,9440.15%
EULAV Asset Management 170,000$3,138,2000.14%
Campbell & CO Investment Adviser LLC 28,390$524,0790.12%
Legato Capital Management LLC 33,442$617,3390.12%
GSA CAPITAL PARTNERS LLP 45,659$8430.10%
ROTHSCHILD & CO ASSET MANAGEMENT US INC. 369,648$6,823,7000.10%
Caption Management, LLC 340,500$6,285,6300.10%
Kula Investments, LLC 17,961$331,5600.10%
AIGEN INVESTMENT MANAGEMENT, LP 36,250$669,1750.10%
NinePointTwo Capital LLC 11,774$2170.09%
OCCUDO QUANTITATIVE STRATEGIES LP 40,752$752,2820.09%
PICTON MAHONEY ASSET MANAGEMENT 99,980$1,8440.09%
BAMCO INC /NY/ 1,257,708$23,217,2900.08%
TWO SIGMA INVESTMENTS, LP 1,351,154$24,942,3030.08%
Dynamic Technology Lab Private Ltd 34,189$6310.06%
Jump Financial, LLC 62,903$1,161,1900.06%
External links

This page lists REVANCE THERAPEUTICS INC's shareholders in Q4 2022. To view REVANCE THERAPEUTICS INC's shareholder history, click here.